- Presentations
- 2
- Markets
- 1
Mavyret is a brand of Glecaprevir and Pibrentasvir marketed by AbbVie, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Glecaprevir and Pibrentasvir
- Brand owner
- AbbVie
- Registered in
- United States
- Strengths and forms
- 50 mg/20 mg oral pellets, 100 mg/40 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Mavyret 50 mg/20 mg oral pelletsOral | AbbVie | US FDA | Available on request |
| Mavyret 100 mg/40 mg tabletOral | AbbVie | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Mavyret
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.